Aizon delivers the only GxP compliant SaaS solutions that enable life sciences manufacturers to aggregate and visualize their manufacturing process data, giving them quick access to actionable insights and predictions through AI deployed and operationalized in a compliant environment. Built on Aizon’s platform, the solutions help manufacturers leverage historic and real-time data to improve their processes, provide transparency, and deliver quality drugs on time and on budget.
Aizon offices are located in San Francisco, California, and Barcelona, Spain. Aizon customers and partners span the globe.

CKA Capital Ltd

La Famiglia

Crosslink Capital

Konstantin von Unger

Honeywell Venture Capital

Atlantic Bridge

ICF Capital

Uncork Capital

Aizon

Aizon Celebrates Thanksgiving! 🍁🦃

This year, we are grateful for a year of growth, collaboration, and shared successes. Thank you to our clients, partners, and team for being part of our journey.

Wishing everyone a joyful holiday surrounded by loved ones. Happy Thanksgiving!



#Thankful #Gratitude #HappyThanksgiving #Aizon

🌐 Exciting News! Aizon is Exhibiting at ISPE Pharma 4.0™ and Annex 1 Conference in Barcelona!

🗓️ December 11th and 12th, 2023

Join us as we delve into the latest innovations, regulatory challenges, and technological advancements shaping the pharma landscape. Our team is eager to meet industry professionals, share valuable insights, and learn from the community's collective wisdom.

🔗 https://aizon.ai/ispe

Let’s connect at ISPE and discover how we can collaborate to drive the future of pharma forward!

#Aizon #ISPE #Pharmaceutical

Volunteers needed!

Aizon is working with PDA - Parenteral Drug Association and the Drug Manufacturing Digitalization Roadmap Team on an initiative originating from PDA's Advanced Manufacturing and Applied Process Digitalization Interest Group. 

The interest group's goal is to facilitate discussion and activities around the implementation of a fully digital drug production through a hands-on approach.

The interest group has developed an extensive list of topics and ideas which could be supported by PDA to aid the industry in digitalization of manufacturing processes.

The team to be assembled will be tasked with conducting a prioritization and gap analysis of those ideas and topics to identify areas of greater need or impact which could benefit from digitalization and which can be addressed by PDA members.

Any PDA Members who would like to participate in this revision effort, please send an email to sci_reg@pda.org to provide your current CV or link to your LinkedIn profile to be considered for the opportunity.

#innovation #digital #manufacturing #lifescienceindustry

On October 20th, we came together for our annual company event, and what a day it was! 
Hosted at the picturesque Masia Rosàs, it was a day filled with laughter, joy and unforgettable moments.💙

Here's a sneak peek of the wonderful day we shared together! ✨




#Aizon #AizonTeam #teambuilding #companyevent #masiarosas

🌍 AI Global Healthcare Initiative's Annual Summit

Excited to announce our attendance at the AFDO/RAPS Healthcare Products Collaborative this year in Cincinnati, Ohio, from November 14-16, 2023!

Toni Manzano - Co-Founder & CSO of Aizon

Lacey Harbour - Regulatory Affairs Manager at Thermo Fisher Scientific

Matt Schmucki - Associate Director of Automation Engineering at Vertex Pharmaceuticals

Will be leading a workshop titled: "AI In Production Workshop: Dealing With Drift." 

Join us to engage and collaborate with regulators, academia, and industry professionals. Dive deep into crucial conversations about the future and impact of AI in healthcare.

🔗 Register link:
https://lnkd.in/eg3Gy_hZ

🔗 Check out the agenda and the full list of speakers for the 2023 Summit: 
https://lnkd.in/eKm-uFG9


Your participation is important. Let's shape the future of AI in Health together!

Don't miss out on their insights!

#AISummit2023 #Aizon #Pharma

🌍 Diving Deep into Pharma Innovations at CPhI Worldwide!

As the event draws closer, our excitement is palpable! Aizon is primed to unveil our latest technological solutions and insights at CPhI Worldwide.

Passionate about the forefront of biopharma, precision medicine, and regulatory compliance? So are we! Let's explore these vital areas together.

🔗 https://lnkd.in/eVdN3xSr

Join us for in-depth discussions on state-of-the-art formulations, the future of drug delivery systems, and the ever-evolving pharma tech landscape. We're eager to exchange our latest findings and learn about your perspectives.

How about a coffee while discussing the future trajectory of pharma?

🔗 https://lnkd.in/eVdN3xSr

See you at CPhI!

#Pharma #CPHI #Aizon #CPHIBarcelona

Webinar: AI-driven solutions boost pharma productivity 53%

Discover how biologics manufacturers achieved a 53% boost in critical downstream process effectiveness with AI. 

Date: October 31, 2023
Time: 11:00 AM ET / 10:00 AM CT / 8:00 AM PT / 3:00 PM GMT / 4:00 PM CET 


Join this webinar to learn how:

 - AI optimizes the pharma "golden batch"
 - Algorithms enhance drug process engineering and quality.
 - Teams identify complex patterns surpassing traditional analyses.

Register now:
🔗 https://lnkd.in/dFx5MZrD

In this session, we'll delve into real-world applications that demonstrate AI's prowess in pharmaceutical settings, and you'll gain a deep appreciation for the benefits of predictive analytics.
These insights are essential for pharma professionals, providing a comprehensive understanding of AI's current role and its boundless potential within the pharmaceutical landscape.

Save my seat:
🔗 https://lnkd.in/dFx5MZrD




#Pharma #AIinPharma #Aizon

Aizon's recent International Food Exchange was a global gastronomic adventure! 🌍

🍽️  Our team shared diverse flavors from around the world, making it a delicious success. 

Stay tuned for more exciting events! 


#Aizon #teambuilding

Introducing Our New eBook: "Unleash the Power of AI in GxP Manufacturing.

📖 Learn how Artificial Intelligence (AI) can unlock new levels of insights into what is causing variations in processes that can wreak havoc on your drug manufacturing performance.


 🔗 Get your free copy now: www.aizon.ai/ebook23

 #AI #GMP #Pharma

🌐 Exciting News! Aizon to Attend CPhI Worldwide in Barcelona! 

🗓️ October 24th to 26th, 2023

We are happy to announce that Aizon will participate in the prestigious CPhI Worldwide event in the beautiful city of Barcelona - our hometown!

Let's discuss the latest trends, developments, and breakthroughs in the pharmaceutical world. Our team is excited to connect with fellow professionals, exchange insights, and share the industry's advancements.

🔗 Connect with us at the event, and let’s explore the collaborative opportunities to innovate and shape the future of pharmaceuticals! 

#Aizon #CPHI #Pharmaceutical

Exscientia is an AI-driven drug discovery company that focuses on automating drug design and optimization processes.

Exscientia

Insitro is a data-driven drug discovery company that leverages machine learning and high-throughput biology to transform the drug discovery process.

Insitro

BenevolentAI is an AI platform that specializes in drug discovery and development, focusing on using AI to accelerate the process of finding new medicines.

BenevolentAI

Oden Technologies is a company focused on intelligent industrial automation within the manufacturing sector, offering manufacturing analytics software and artificial intelligence solutions for production processes.

Oden Technologies

Aizon provides GxP compliant solutions and AI to empower CDMOs and Life Sciences Manufacturers by leveraging historic and real-time data to improve processes, provide transparency, and deliver quality drugs on time and on budget.

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Feb 8, 2024 7:00 PM	4bc2520d
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 8, 2024 7:00 PM	df305b39
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general	Feb 8, 2024 7:00 PM	1afa3409
news basic	general	Feb 8, 2024 7:00 PM	85cb004c
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
purchaser profile	merger_acquisitions
customer profile	customers

AI:AIZON

Aizon